Consultant Ophthalmic Surgeon Mr Mfazo Hove, Founder of Blue Fin Vision®, has been confirmed as a ZEISS faculty speaker and advisor for a series of major ...
Las Vegas, NV / / December 24, 2025 / ContrastConnect Key Takeaways CMS has permanently authorized virtual contrast supervision beginning January 1, 2026, allowing radiologists to oversee contrast ...
Today, ZEISS marks 100 years of operation in the U.S., helping Americans improve lives and reach profound achievements by applying the company's innovative technologies to research, healthcare, ...
Even the most advanced CMMS will fail if technicians find it difficult to use. User adoption is often the determining factor in whether digital maintenance transitions succeed. Vendors should offer ...
At SEMICON Taiwan 2025, Zeiss Semiconductor Manufacturing Technology offered a rare glimpse into the future of extreme ultraviolet (EUV) lithography, outlining its optics roadmap from High NA to the ...
Carl Zeiss Meditec is significantly undervalued after the 9M25 results, with the market overreaction creating a compelling entry point for long-term investors. Despite short-term margin pressures and ...
Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices, or OPT, and microsurgery, or MCS.
Abstract: This article presents the first publicly available study for comprehensive characterizations of an FPGA-based Samsung’s CXL Memory Module Hybrid (CMM-H) prototype. It leverages emerging CXL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback